期刊文献+

甲状腺乳头状癌p53基因突变及其与p21^(WAF1/CIP1)蛋白定量表达的关系 被引量:4

P53-gene Mutation and its Relation with Quantitative Expressionof the P21~(WAF1/CIP1 Protein in Papillary Thyroid Carcinoma
暂未订购
导出
摘要 目的 初步探讨甲状腺乳头状癌 (PTC)中 p5 3基因突变及其与 p2 1WAF1 /CIP1 蛋白定量表达的关系。 方法 采用 PCR- SSCP、DNA序列分析、免疫组织化学、图像分析等技术 ,检测 4 1例 PTC和 10例甲状腺滤泡性腺瘤标本组织中 p5 3基因突变情况和 p2 1蛋白染色状况。 结果  (1)伴 p5 3基因突变 ( 组 )和不伴突变 ( 组 ) PTC的原发肿瘤 (T)、淋巴结转移 (N)及远处转移 (M)差异无显著性 (P>0 .0 5 )。 (2 ) 、 和 之间 , 和 、 和 、 和 的平均积分光密度值 (D)差异具有显著性意义 (P<0 .0 1)。 结论  (1) PTC的演进和 p5 3基因突变与否无直接关系 ,p5 3蛋白的空间构象可能发挥关键作用。 (2 )在 PTC的发生、发展中存在依赖野生型 p5 3蛋白诱导P2 1WAF 1 Objective\ To explore p53\|gene mutation and its relation with quantitative expression of the p21\+\{WAF1/CIP1\} protein in papillary thyroid carcinoma(PTC).\ Methods\ Seventeen archive samples enrolled in group Ⅰ, tweenty liquer nitrogen PTC storage samples.\ P53 gene purified with polymerase chain reaction single strand comformational polymorphism(PCR\|SSCP) method.\ P21 expression was quantitatively by mean optical density(D) method.\ Results\ (1)There were no statistically significant differences between group Ⅱ(without p53 gene mutation) and group Ⅰ(with p53 gene mutation) PTC in T, N, M(P>0 05).\ (2)The difference of D among group Ⅰ, group Ⅱ and group Ⅲ was statistically significant(P<0 01).\ The D levels between group Ⅲ and group Ⅱ PTC, group Ⅱ and group Ⅰ ones, group Ⅲ and group Ⅰ ones were also significantly different(P<0 01).\ Conclusion\ (1)There is no direct relationship between the progression of PTC and the p53\|gene mutation.\ (2)The expression of p21\+\{WAF1/CIP1\} in PTC is induced by wild p53\|protein, which serve as a regulative route during carcinogenesis and development of PTC.
出处 《福建医科大学学报》 2003年第3期263-265,F002,共4页 Journal of Fujian Medical University
基金 福建省科技厅医药卫生科技攻关计划资助项目 ( 99-Z-2 0 8)
关键词 甲状腺肿瘤 乳头状 蛋白质P53 基因 p53 原癌基因蛋白质P21(ras) 免疫组织化学 thyroid neoplasms carcinoma,papilliform protein p53 gene,p53 proto\|oncogene protein p21(ras) immunohistochemistry
  • 相关文献

参考文献8

  • 1陈一峰,张鹏飞,李一伟,庄建良,高凌云.甲状腺乳头状癌中p53蛋白三维空间结构改变的临床病理研究[J].中华病理学杂志,2002,31(3):217-221. 被引量:8
  • 2陈一峰,张鹏飞,李一伟,高凌云,庄建良.P27^(kip1)蛋白在甲状腺乳头状癌的定量表达及其与P53的关系[J].福建医科大学学报,2002,36(1):33-35. 被引量:1
  • 3Kim D,Gregory CW,Smith GJ, et al. Immunohistochemical quantitation of androgen receptor expression using color video image analysis[J]. Cytometry, 1999,35(1):2-10.
  • 4Mady HH,Melhem MF. FHIT protein expression and its relation to apoptosis,tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study[J]. Clin Exp Metastasis, 2002, 19 ( 4 ), 351-358.
  • 5Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption[J].Mol Cell Biol, 1998,18(2):1055-1064.
  • 6Garkavtsev I, Grigorian IA, Ossovskaya VS, et al.The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control[J]. Nature, 1998,391(6664) :295-298.
  • 7Makri D,Schulz WA,Grimm M,et al. WAF1/p21 regulates proliferation, but does not mediate p53 dependent apoptosis in urothelial carcinoma cell lines[J]. Int J Oncol, 1998,12(3):621
  • 8Marchetti A,Doglioni C,Barbareschi M,et al. p21 RNA and protein expression in non-small cell lung carcinomas:evidence of p53 indepent expression and association with tumoral differentiation[J]. Oncogene, 1996,12(6) :1319-1324.

二级参考文献2

共引文献7

同被引文献34

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部